Nebenwirkungen · Afqlir
Afqlir 40 mg/ml solution for injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 8
HOS-151726 · Präparat HOS-100603
System Organ Class Frequency Adverse reaction Immune system disorders Uncommon Hypersensitivity*** Eye disorders Very common Visual acuity reduced, Retinal haemorrhage, Conjunctival haemorrhage, Eye pain Common Retinal pigment epithelial tear*, Detachment of the retinal pigment epithelium, Retinal degeneration, Vitreous haemorrhage, Cataract, Cataract cortical, Cataract nuclear, Cataract subcapsular, Corneal erosion, Corneal abrasion, Intraocular pressure increased, Vision blurred, Vitreous floaters, Vitreous detachment, Injection site pain, Foreign body sensation in eyes, Lacrimation increased, Eyelid oedema, Injection site haemorrhage, Punctate keratitis, Conjunctival hyperaemia, Ocular hyperaemia Uncommon Endophthalmitis**, Retinal detachment, Retinal tear, Iritis, Uveitis, Iridocyclitis, Lenticular opacities, Corneal epithelium defect, Injection site irritation, Abnormal sensation in eye, Eyelid irritation, Anterior chamber flare, Corneal oedema Blindness, Retinal vasculitis, Cataract traumatic, Rare Vitritis, Hypopyon Not known Retinal occlusive vasculitis****, Scleritis****
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-20T15:00:00Z · SHA-256 19885184aef187561f3817f4ea36b27d2bf1894a75377222dd74796e0ffb82f9 · Passage 7a0ac4bcd97e909819a3dfab6be5006b503a416bacd93aab1732d60915842c59 · Zeichen 1817–4075 im Abschnitt